195 related articles for article (PubMed ID: 10591973)
1. [Present importance of direct immunologically based intervention strategies using anticytokines in rheumatoid arthritis].
Boehme MW; Gao IK
Z Rheumatol; 1999 Oct; 58(5):251-66. PubMed ID: 10591973
[TBL] [Abstract][Full Text] [Related]
2. [New drugs and treatment strategies for rheumatoid arthritis].
Fantini F
Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
[TBL] [Abstract][Full Text] [Related]
3. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
[TBL] [Abstract][Full Text] [Related]
4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
5. Anti-cytokines and cytokines in the treatment of rheumatoid arthritis.
Taylor PC
Curr Pharm Des; 2003; 9(14):1095-106. PubMed ID: 12769749
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.
Fleischmann R; Iqbal I; Nandeshwar P; Quiceno A
Drug Saf; 2002; 25(3):173-97. PubMed ID: 11945114
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of rheumatoid arthritis (RA) with anticytokines].
Feuchtenberger M; Kneitz C; Tony HP
MMW Fortschr Med; 2006 Oct; 148(42):44-5, 47. PubMed ID: 17621799
[TBL] [Abstract][Full Text] [Related]
8. Biological response modifiers in the management of rheumatoid arthritis.
Louie SG; Park B; Yoon H
Am J Health Syst Pharm; 2003 Feb; 60(4):346-55. PubMed ID: 12625216
[TBL] [Abstract][Full Text] [Related]
9. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
Alam J; Jantan I; Bukhari SNA
Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of rheumatoid arthritis: targeting cytokines.
Zwerina J; Redlich K; Schett G; Smolen JS
Ann N Y Acad Sci; 2005 Jun; 1051():716-29. PubMed ID: 16127012
[TBL] [Abstract][Full Text] [Related]
12. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson SB; Amin A
Rheumatology (Oxford); 2002 Sep; 41(9):972-80. PubMed ID: 12209029
[TBL] [Abstract][Full Text] [Related]
13. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
14. [Interleukins network in rheumatoid arthritis pathophysiology: beyond proinflammatory cytokines].
Sánchez-Ramón S; López-Longo FJ; Carreño L
Reumatol Clin; 2011 Mar; 6S3():S20-4. PubMed ID: 21794767
[TBL] [Abstract][Full Text] [Related]
15. Modern treatment strategies in rheumatoid arthritis.
Hetland ML
Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935
[TBL] [Abstract][Full Text] [Related]
16. Anti-cytokine therapy for rheumatoid arthritis.
Maini RN; Taylor PC
Annu Rev Med; 2000; 51():207-29. PubMed ID: 10774461
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic use of "biologics" in inflammatory joint and spinal diseases].
Seitz M
Ther Umsch; 2002 Oct; 59(10):535-43. PubMed ID: 12428439
[TBL] [Abstract][Full Text] [Related]
18. New therapies for rheumatoid arthritis.
Goldblatt F; Isenberg DA
Clin Exp Immunol; 2005 May; 140(2):195-204. PubMed ID: 15807842
[TBL] [Abstract][Full Text] [Related]
19. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
Dayer JM
Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii3-10. PubMed ID: 12817089
[TBL] [Abstract][Full Text] [Related]
20. Embracing novel cytokines in RA - complexity grows as does opportunity!
Hueber AJ; Asquith DL; McInnes IB; Miller AM
Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):479-87. PubMed ID: 20732646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
